Cargando…
A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease
PURPOSE: To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease. OBSERVATIONS: A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagnosis. The patient noted progression of her disease...
Autores principales: | Safo, Myra B., Silkiss, Rona Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008157/ https://www.ncbi.nlm.nih.gov/pubmed/33817409 http://dx.doi.org/10.1016/j.ajoc.2021.101069 |
Ejemplares similares
-
Teprotumumab-associated chronic hearing loss screening and proposed treatments
por: Chow, Audrey, et al.
Publicado: (2022) -
Teprotumumab in advanced reactivated thyroid eye disease
por: Cheng, Olivia T., et al.
Publicado: (2022) -
Teprotumumab for the treatment of chronic thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2021) -
Orbital lymphocyte populations in three states of thyroid eye disease
por: Griffin, Shane M., et al.
Publicado: (2023) -
Early experience with teprotumumab for chronic thyroid eye disease
por: Ozzello, Daniel J., et al.
Publicado: (2020)